Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bauernfeind

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Infection|May 1, 1992
A new plasmidic cefotaximase from patients infected with Salmonella typhimuriumA Bauernfeind, J M Casellas, M Goldberg, et al.
International Journal of Antimicrobial Agents|July 24, 2002
Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parametersF M E Wagenlehner, S Krcmery, C Held, et al.
Journal of Clinical Microbiology|March 1, 1996
Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transferW M Prodinger, M Fille, A Bauernfeind, et al.
American Heart Journal|August 1, 1982
Exercise provocable right ventricular outflow tract tachycardiaE V Palileo, W W Ashley, S Swiryn, et al.
The American Journal of Cardiology|April 1, 1980
Treadmill exercise testing in the Wolff-Parkinson-White syndromeB Strasberg, W W Ashley, C R Wyndham, et al.
The Journal of Antibiotics|April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitroA Bauernfeind, R Jungwirth, E Eberlein, et al.
The European Respiratory Journal|December 31, 2002
Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patientsA Jung, I Kleinau, G Schönian, et al.
The American Journal of Cardiology|June 1, 1980
Cycle length in atrioventricular nodal reentrant paroxysmal tachycardia with observations on the Lown-Ganong-Levine syndromeR A Bauernfeind, B F Ayres, C C Wyndham, et al.
The Journal of Antibiotics|April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteinsA Markus, N Klesel, T Wollmann, et al.
Infection|January 1, 1989
[In-vitro activity of enoxacin: a multicenter study]B Wiedemann, D Adam, A Bauernfeind, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Infection|May 1, 1992
A new plasmidic cefotaximase from patients infected with Salmonella typhimuriumA Bauernfeind, J M Casellas, M Goldberg, et al.
International Journal of Antimicrobial Agents|July 24, 2002
Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parametersF M E Wagenlehner, S Krcmery, C Held, et al.
Journal of Clinical Microbiology|March 1, 1996
Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transferW M Prodinger, M Fille, A Bauernfeind, et al.
American Heart Journal|August 1, 1982
Exercise provocable right ventricular outflow tract tachycardiaE V Palileo, W W Ashley, S Swiryn, et al.
The American Journal of Cardiology|April 1, 1980
Treadmill exercise testing in the Wolff-Parkinson-White syndromeB Strasberg, W W Ashley, C R Wyndham, et al.
The Journal of Antibiotics|April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitroA Bauernfeind, R Jungwirth, E Eberlein, et al.
The European Respiratory Journal|December 31, 2002
Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patientsA Jung, I Kleinau, G Schönian, et al.
The American Journal of Cardiology|June 1, 1980
Cycle length in atrioventricular nodal reentrant paroxysmal tachycardia with observations on the Lown-Ganong-Levine syndromeR A Bauernfeind, B F Ayres, C C Wyndham, et al.
The Journal of Antibiotics|April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteinsA Markus, N Klesel, T Wollmann, et al.
Infection|January 1, 1989
[In-vitro activity of enoxacin: a multicenter study]B Wiedemann, D Adam, A Bauernfeind, et al.
Pageof 18